Data / Drug companies / Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited: 41 products in the FDA NDC directory, labeler code 72643
Solara Active Pharma Sciences Limited (labeler code 72643) lists 41 products in the FDA National Drug Code Directory. By type: 41 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 1, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 72643
- Products in commercial distribution
- 41
- Packages
- 85
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 2, Schedule V 1
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 1, 1982
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 41 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 41 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 41 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Mycophenolate mofetil | 72643-041 | Powder | Bulk ingredients | May 1, 2025 |
| Ibuprofen sodium dihydrate | 72643-040 | Powder | Bulk ingredients | March 3, 2025 |
| Dexibuprofen | 72643-042 | Powder | Bulk ingredients | January 1, 2025 |
| Rotigotine | 72643-039 | Powder | Bulk ingredients | March 28, 2024 |
| Felbamate | 72643-037 | Powder | Bulk ingredients | March 14, 2024 |
| Buspirone hydrochloride | 72643-036 | Powder | Bulk ingredients | July 31, 2023 |
| Mebendazole | 72643-035 | Powder | Bulk ingredients | June 30, 2023 |
| Edaravone | 72643-034 | Powder | Bulk ingredients | May 23, 2023 |
| Chlropromazine hydrochloride | 72643-033 | Powder | Bulk ingredients | May 18, 2023 |
| Pentoxifylline | 72643-032 | Powder | Bulk ingredients | February 2, 2023 |
| Lurasidone hydrochloride | 72643-031 | Powder | Bulk ingredients | December 30, 2022 |
| Bumetanide | 72643-030 | Powder | Bulk ingredients | November 8, 2022 |
| Tioconazole | 72643-029 | Powder | Bulk ingredients | July 6, 2022 |
| Disulfiram | 72643-028 | Powder | Bulk ingredients | March 7, 2022 |
| Cycloserine | 72643-027 | Powder | Bulk ingredients | November 9, 2021 |
| Sapropterin dihydrochloride | 72643-026 | Powder | Bulk ingredients | September 21, 2021 |
| Levetiracetam | 72643-025 | Powder | Bulk ingredients | July 16, 2020 |
| Suggamadex sodium | 72643-024 | Powder | Bulk ingredients | June 10, 2020 |
| Olanzapine | 72643-023 | Powder | Bulk ingredients | May 25, 2020 |
| Zileuton | 72643-022 | Powder | Bulk ingredients | April 16, 2020 |
| Methohexital | 72643-021 | Powder | Bulk ingredients | March 16, 2020 |
| Aprepitant | 72643-020 | Powder | Bulk ingredients | February 20, 2020 |
| Colestipol hydrochloride | 72643-019 | Powder | Bulk ingredients | February 18, 2020 |
| Patiromer sorbitex calcium | 72643-016 | Powder | Bulk ingredients | April 10, 2019 |
| N-(((1r,2r)-2-(2,3- dihydrobenzofuran-4-yl)cyclopropyl)methyl) propionamide | 72643-015 | Powder | Bulk ingredients | March 29, 2019 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.